XML 79 R67.htm IDEA: XBRL DOCUMENT v3.25.1
Derivative Financial Instruments - Additional Information (Detail) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 17, 2024
Mar. 06, 2023
Jun. 14, 2021
Dec. 12, 2020
Jun. 14, 2019
Jan. 31, 2020
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]                  
Litigation Settlement Loans Payable             $ 0 $ 1,000,000  
Debt discount amount             1,906,850 3,955,449  
Fair value of the obligation             57,000,000 52,100,000  
Asset at fair value, changes in fair value resulting from changes in assumptions             4,800,000 6,700,000  
Derivative liability             3,052,000 0  
Change in derivative liabilities fair value             18,866,862 $ (8,302,866)  
Litigation settlement, amount awarded from Mexico $ 37,100,000                
March 2023 Notes [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Derivative liability             2,700,000    
Change in derivative liabilities fair value             2,100,000    
December 2023 Notes [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Derivative liability             300,000    
Change in derivative liabilities fair value             100,000    
Amended and Restated International Claims Enforcement Agreement [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Litigation Settlement Loans Payable           $ 2,200,000      
Litigation Settlement Loans Payable Transaction Costs           $ 200,000      
Common stock and warrants sold           3.99      
Second Amended and Restated International Claims Enforcement Agreement [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims Payment Maximum Amount       $ 20,000,000          
Litigation Settlement Loans Payable Transaction Costs       200,000          
Third Amended And Restated International Claims Enforcement Agreement [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims Payment Maximum Amount     $ 25,000,000            
Litigation Settlement Loans Payable Transaction Costs             $ 80,000    
Increase decrease in claims amount agreed to be financed in connection with litigation to be settled     $ 5,000,000            
Claims amount agreed to be financed in connection with litigation to be settled description             The Third Restated Agreement requires the Claimholder to request $2.5 million of the Incremental Amount (the "First $2.5 Million"). Within 15 days after exhaustion of the First $2.5 Million, the Claimholder may either (a) request the remaining $2.5 million (the "Second $2.5 Million") of the Incremental Amount or (b) notify the Funder that the Claimholder has decided to self-fund the Second $2.5 Million.    
Aggregate amount             $ 24,800,000    
Waiver Agreement [Member] | Litigation Financing [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims Payment Maximum Amount   $ 5,000,000              
Nonrefundable fee   $ 1,000,000              
Phase Three [Member] | Second Amended and Restated International Claims Enforcement Agreement [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims Payment Maximum Amount       $ 10,000,000          
Pending Litigation [Member] | Phase One [Member] | Proceeds One [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Description of conditions for distribution of proceeds to the claimholder and funder             first, 100.0% to the Funder, until the cumulative amount distributed to the Funder equals the total Claims Payments paid by the Funder under Phase I;    
Pending Litigation [Member] | Phase One [Member] | Proceeds Two [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Description of conditions for distribution of proceeds to the claimholder and funder             second, 100.0% to the Funder until the cumulative amount distributed to the Funder equals an IRR of 20% of Claims Payments paid by the Funder under Phase I ("Phase I Compensation"), per annum; and    
Pending Litigation [Member] | Phase One [Member] | Proceeds Three [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Description of conditions for distribution of proceeds to the claimholder and funder             thereafter, 100.0% to the Claimholder.    
Pending Litigation [Member] | Phase Two [Member] | Proceeds One [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Description of conditions for distribution of proceeds to the claimholder and funder             first, 100.0% to the Funder until the cumulative amount distributed to the Funder equals the total Claims Payments paid by the Funder under Phases I and II;    
Pending Litigation [Member] | Phase Two [Member] | Proceeds Two [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Description of conditions for distribution of proceeds to the claimholder and funder             second, 100.0% to the Funder until the cumulative amount distributed to the Funder equals an additional 300.0% of Phase I Investment Amount; plus an additional 300% of the Tranche A Committed Amount (i.e. 300.0% of $3.5 million), less any amounts remaining of the Tranche A Committed Amount that​​​​​​​ the Funder did not pay as Claims Payments; plus an additional 300.0% of the Tranche B Committed Amount (i.e. 300.0% of $1.5 million), if the Claimholder exercises the Tranche B funding option, less any amounts remaining of the Tranche B Committed Amount that the Funder did not pay as Claims Payments;    
Pending Litigation [Member] | Phase Two [Member] | Proceeds Three [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Description of conditions for distribution of proceeds to the claimholder and funder             third, for each $10,000 in specified fees and expenses paid by the Funder under Phase I and Phase II and any amounts over each $10,000 of the Tranche A Committed Amount and the Tranche B Committed Amount (if the Claimholder exercises the Tranche B funding option), 0.01% of the total Proceeds from any recoveries after repayment of (i) and (ii) above, to the Funder; and    
Pending Litigation [Member] | Phase Two [Member] | Proceeds Four [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Description of conditions for distribution of proceeds to the claimholder and funder             thereafter, 100% to the Claimholder.    
Poplar Falls LLC [Member] | Pending Litigation [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims Payment Maximum Amount         $ 6,500,000        
Proceeds from advance                 $ 2,000,000
Payments of Financing Costs                 200,000
Debt discount amount                 $ 1,100,000
Poplar Falls LLC [Member] | Pending Litigation [Member] | Phase One [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims Payment Maximum Amount         1,500,000        
Cost Of Funding The Claims For Litigation         80,000        
Poplar Falls LLC [Member] | Pending Litigation [Member] | Phase Two [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims Payment Maximum Amount         5,000,000        
Cost Of Funding The Claims For Litigation         80,000        
Poplar Falls LLC [Member] | Pending Litigation [Member] | Phase Two [Member] | Tranch A [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims amount option to request         3,500,000        
Poplar Falls LLC [Member] | Pending Litigation [Member] | Phase Two [Member] | Tranch B [Member]                  
Derivative Instruments, Gain (Loss) [Line Items]                  
Claims amount option to request         $ 1,500,000